Page 12 - CANNABIS NEWS FLORIDA DECEMBER 2019

CBD in the Data

CBD. If Cannabis has Yes. Take for example the session (at 14% of CBD-only sessions) ical profiles. This suggests that a person’s
brought you to this article FDA’s approval of with CBD-Only products by around ECS, who has muscle pain and/or
you have undoubtedly Epidiolex, which is an 10,000 more sessions than the next two inflammation, may have a further inter-
heard of this three-letter almost pure CBD pharma- symptoms CBD-only products are most action with other active molecules out-
acronym. What is CBD ceutical grade drug used used for. Anxiety(11% of CBD-Only ses- side of CBD which can make products
though? Does it work and for seizures. People are sions), Joint pain(11% of CBD-Only ses- more effective for those symptoms.
what is it working for? finding relief both anecdo- sions), and inflammation(10% of CBD- There is a large amount of promise for
CBD stands for tally and alongside a med- Only sessions), round out the top four CBD in psychological symptoms such as
Cannabadiol, which ical professional for sever- symptoms that patients are utilizing anxiety, irritability, and challenge con-
behind THC (Tetrahydro - al other conditions and CBD-only products for, but this contra- centrating. These three symptoms have
cannabinol) is the most symptoms. Pain and dicts some of the data showing what it is been shown to be the most efficacious
prevalent active molecule inflammation are two of best for. with efficacy at 47% for irritability and
in the Cannabis plant. In the symptoms most treat- Strainprint’s data is collected in the 46% for both anxiety and challenge con-
order to get to the CBD BY KASHTON FOLEY ed with CBD and also two model of a stage 4 real-world evidence centrating. Suggesting that more people
that most people are that show some of the trial and collects an efficacy score for seeking relief from these symptoms
using in the U.S. the orig- most promise for finding products against symptoms. This efficacy should try CBD-only products. CBD
inal molecule, CBDA “cannabidiolic relief with CBD. Because of this promise score shows the percentage of relief or products are showing promise of relief
acid”, it must be decarboxylated or heat- the general public has largely been self- symptom improvement a product brings with less side effects than other over the
ed up which removes the acid. Unlike medicating with CBD for a range of ail- a patient by taking a score of 1-10 before counter drugs, but Strainprint’s data
THC, CBD does not cause the intoxicat- ments. and after use. Looking into this data shows that not all symptoms are finding
ing euphoric effects most commonly In lieu of clinical research clearing the muscle pain and inflammation show the the same level of relief. Patients should
thought of when talking about the way for medical doctors to be able to pre- lowest level of efficacy for the top 4 most make sure to track their usage with
Cannabis plant. The lack of euphoric cisely prescribe CBD products to relieve treated symptoms at 25% and 22% effica- Strainprint and consult a medical profes-
effects has made this molecule widely specific systems data, more specifically cy respectively. Both of those efficacy sional when utilizing CBD products.
about to the general public, but where is BIG Data, shows some clear patterns of scores nearly double where a slight
all of the data and how does it work? symptoms that CBD is relieving. amount of THC and other minor For more information, visit strainprint.ca.
The endocannabinoid system or ECS Strainprint Technologies Inc. has the cannabinoids are active in product chem-
for short is the human body’s physiolog- largest real-word evidence database in
ical system that is made up of receptors the world of patient reported outcomes
(amongst other biological molecules) from Cannabis use, with over 350,000
and where the Cannabis plant’s active patient reported outcomes that stem
molecules interact with the human body. from CBD-Only Products.
The two most studied receptors, Over 25% of Strainprint’s overall data-
CB1(Nervous System receptors) and base holds efficacy records from CBD-
CB2(Immune system and Nervous only products. This large of an observa-
System receptors), are where CBD inter- tional study allows both doctors and
acts with the body. Unlike THC, CBD is patients to utilize aggregated data to
able to interact with both CB1 and CB2 understand which products are working
receptors. This means that as a potential best for which symptoms and potentially
medicine CBD has promise as a therapy what active minor cannabinoids/ ter-
for not only the nervous system, but also penes are common in effective products.
physical conditions and symptoms. The data is showing that muscle pain is
Does it work? The simple answer is the symptom that has the most tracked

www.CannabisNewsFlorida.com
Visit us on the web at www.CannabisNewsFlorida.com

Cannabis News Florida cannabisnewsflorida.com December 2019 33